Aplotaxis Amomum Pills Xiang Sha Liu Jun Wan
On sale on the US market (according to the DSLD)
Min Shan, food supplement from the US market
Aplotaxis Amomum Pills Xiang Sha Liu Jun Wan (Min Shan), a food supplement without a usable barcode in DSLD, is described by its US market label. If sold in France, it would be subject to 1 point of French or European regulation, detailed below. The formula sold in Europe under the same name may differ.
Official label. Dietary Supplement Label Database (DSLD), US National Institutes of Health: current and off-market labels, retrieved 27 October 2026.
Source: NIH Office of Dietary Supplements, Dietary Supplement Label Database (CC0); US market labels.
If this product were sold in France
- Conditions légales
Glycyrrhiza uralensis Fisch.: La portion journalière recommandée ne doit pas conduire à une ingestion d'acide glycyrrhizinique supérieure à 100 mg. L'étiquetage doit comporter un avertissement avec la teneur suivante: "Ne pas utiliser pendant plus de 6 semaines sans avis médical." L'étiquetage doit comporter un avertissement déconseillant l'emploi chez les enfants.
Source: French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, arrêté du 24 juin 2014, annexe I.
A daily dose is calculated only if the label gives the maximum number of servings and a unit of mass (or international units for vitamin D). Quantities come from the label, not an analysis. In the United States, the label presents this product as a ‘dietary supplement’; in France, a product of this type may belong to another category (a sports powder, for example), and maximum food supplement doses do not apply to it.
Label composition
- Brand
- Min Shan
- Barcode
- Not provided or invalid in DSLD
- Form
- Tablet
- One serving
- « 8 Pill(s) »
- Servings
- up to 3 servings per day
- Other ingredients (in English, as written)
- Dextrin, Magnesium Silicate, Hydrated, China Wax
| Ingredient (as written, in English) | Category | Per serving |
|---|---|---|
| Proprietary Extract Blend | Blend | 1,360 mg |
| Atractylodes macrocephala Rhizome Extract | Plant | not stated |
| Poria cocos Sclerotium Extract | Plant | not stated |
| Codonopsis pilosula Root Extract (Codonopsis pilosula) | Plant | not stated |
| Pinellia ternata Rhizome Extract (Pinellia ternata) | Plant | not stated |
| Citrus reticulata Peel Extract | Plant | not stated |
| Amomum longiligulare Fruit Extract | Plant | not stated |
| Aucklandia lappa Root Extract (Saussurea costus) | Plant | not stated |
| Glycyrrhiza uralensis Root Extract (Glycyrrhiza uralensis) | Plant | not stated |
| Ziziphus jujuba Fruit Extract | Plant | not stated |
| Zingiber officinale Rhizome Extract | Plant | not stated |
Displayed label: Official label. Labels on the market are prioritised, followed by the most recent for the same status.
Other versions of this label
The differences below describe each other version relative to the label shown on this page. They concern active ingredient rows and quantities per serving as written. Missing quantities are not estimated and different units are not converted. Dates refer to entry into DSLD, not necessarily to a formula change.
Official label: Aplotaxis Amomum Pills Xiang Sha Liu Jun Wan
Entered into DSLD on 22 December 2017. Withdrawn from the US market on 28 April 2022 (according to the DSLD).- Active ingredient added : Amomum longiligulare (quantity not stated)
- Active ingredient added : Atractylodes macrocephala (quantity not stated)
- Active ingredient added : Aucklandia lappa (quantity not stated)
- Active ingredient added : Citrus reticulata (quantity not stated)
- Active ingredient added : Codonopsis pilosula (quantity not stated)
- Active ingredient added : Glycyrrhiza uralensis (quantity not stated)
- Active ingredient added : Pinellia ternata (quantity not stated)
- Active ingredient added : Poria cocos sclerotium (quantity not stated)
- Active ingredient added : Zingiber officinale (quantity not stated)
- Active ingredient added : Ziziphus jujuba (quantity not stated)
- Active ingredient removed : Amomum longiligulare Fruit Extract (quantity not stated)
- Active ingredient removed : Atractylodes macrocephala Rhizome Extract (quantity not stated)
- Active ingredient removed : Aucklandia lappa Root Extract (quantity not stated)
- Active ingredient removed : Citrus reticulata Peel Extract (quantity not stated)
- Active ingredient removed : Codonopsis pilosula Root Extract (quantity not stated)
- Active ingredient removed : Glycyrrhiza uralensis Root Extract (quantity not stated)
- Active ingredient removed : Pinellia ternata Rhizome Extract (quantity not stated)
- Active ingredient removed : Poria cocos Sclerotium Extract (quantity not stated)
- Active ingredient removed : Zingiber officinale Rhizome Extract (quantity not stated)
- Active ingredient removed : Ziziphus jujuba Fruit Extract (quantity not stated)
This information reproduces the US label recorded by the US National Institutes of Health (NIH). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.
Official warnings (Health Canada)
Health Canada publishes warnings on these ingredients:
- Glycyrrhiza uralensis Root Extract
Read the warning, when it applies and the studies cited
DEGLYCYRRHIZINATED LICORICE Buccal
Cautions and warnings
Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.
Health Canada monograph dated 31 October 2025
Deglycyrrhizinated Licorice Oral
Cautions and warnings
Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.
Health Canada monograph dated 31 January 2025
LICORICE
Route of administration: Oral
Cautions and warnings
Condition of application: All products.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are breastfeeding (Gardner and McGuffin 2013).
Sources cited by Health Canada (1)
- Gardner Z, McGuffin M. editors. 2013. American Herbal Products Association's Botanical Safety Handbook, 2nd edition. Boca Raton (FL): CRC Press.
Condition of application: Cough relief.
Ask a health care practitioner/health care provider/health care professional/doctor/physician if cough worsens or persists (for) more than 1 week (EMA 2012).
Sources cited by Health Canada (1)
- EMA 2012. European Medicines Agency. Community Herbal Monograph on Glycyrrhiza glabra L. and/or Glycyrrhiza inflata Bat. and/or Glycyrrhiza uralensis Fisch., radix. London (UK): EMA Committee on Herbal Medicinal Products (HMPC), 22 May 2012. [Accessed 2024 January 6]. Available from: https://www.ema.europa.eu/en/documents/herbal-monograph/final-community-herbal-monograph-glycyrrhiza-glabra-l-andor-glycyrrhiza-inflata-bat-andor-glycyrrhiza-uralensis-fisch-radix-first-version_en.pdf
Condition of application: Gastritis relief.
Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.
Contraindications
Condition of application: All products.
Do not use if you are pregnant (EMA 2012).
Sources cited by Health Canada (2)
- EMA 2012. European Medicines Agency. Community Herbal Monograph on Glycyrrhiza glabra L. and/or Glycyrrhiza inflata Bat. and/or Glycyrrhiza uralensis Fisch., radix. London (UK): EMA Committee on Herbal Medicinal Products (HMPC), 22 May 2012. [Accessed 2024 January 6]. Available from: https://www.ema.europa.eu/en/documents/herbal-monograph/final-community-herbal-monograph-glycyrrhiza-glabra-l-andor-glycyrrhiza-inflata-bat-andor-glycyrrhiza-uralensis-fisch-radix-first-version_en.pdf
- Gardner Z, McGuffin M. éditeurs. 2013. American Herbal Products Association's Botanical Safety Handbook, 2e édition. Boca Raton (FL): CRC Press.
Do not use if you have hypokalemia, high blood pressure, or a kidney, liver or cardiovascular disorder (EMA 2012; Brinker 2010; ESCOP 2003; Bradley 1992).
Sources cited by Health Canada (4)
- Bradley PR, editor. British Herbal Compendium: A Handbook of Scientific Information on Widely Used Plant Drugs, Volume 1. Bournemouth (UK): British Herbal Medicine Association; 1992.
- Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.
- EMA 2012. European Medicines Agency. Community Herbal Monograph on Glycyrrhiza glabra L. and/or Glycyrrhiza inflata Bat. and/or Glycyrrhiza uralensis Fisch., radix. London (UK): EMA Committee on Herbal Medicinal Products (HMPC), 22 May 2012. [Accessed 2024 January 6]. Available from: https://www.ema.europa.eu/en/documents/herbal-monograph/final-community-herbal-monograph-glycyrrhiza-glabra-l-andor-glycyrrhiza-inflata-bat-andor-glycyrrhiza-uralensis-fisch-radix-first-version_en.pdf
- ESCOP 2003: ESCOP Monographs: The Scientific Foundation for Herbal Medicinal Products, 2nd edition. Exeter (UK): European Scientific Cooperative on Phytotherapy and Thieme; 2003.
Do not use if you are taking heart medications, corticosteroids, stimulant laxatives, or other health products that may contribute electrolyte imbalance (Brinker 2010; ESCOP 2003; Hoffmann 2003; Blumenthal et al. 2000).
Sources cited by Health Canada (4)
- Blumenthal M, Goldberg A, Brinkmann J, editors. Herbal Medicine: Expanded Commission E Monographs. Boston (MA): Integrative Medicine Communications; 2000.
- Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.
- ESCOP 2003: ESCOP Monographs: The Scientific Foundation for Herbal Medicinal Products, 2nd edition. Exeter (UK): European Scientific Cooperative on Phytotherapy and Thieme; 2003.
- Hoffmann D. Medical Herbalism. Rochester (VT): Healing Arts Press; 2003.
They concern the ingredient, not this product or its dose. They do not replace medical advice.
List declared on (register: Dietary Supplement Label Database (DSLD), US National Institutes of Health: current and off-market labels).
Brand : Min Shan
Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.
Cite this page: CompoAtlas, “Aplotaxis Amomum Pills Xiang Sha Liu Jun Wan (Min Shan): composition and French regulation”, https://compoatlas.com/en/supplements/us-labels/dsld-298539-aplotaxis-amomum-pills-xiang-sha-liu-jun-wan-min-shan, updated 14 December 2023.